Sanketa Save Kohale

My question was on the seasonality actually. For us, Q2, Q3 normally are strong quarters. How has been the start for this quarter? I mean could you please highlight 2, 3 indicators that we can watch out for?

Right, right. Okay. The second question was on recent acquisition. You have already answered, but then I would like to know about the Malad unit. What would be the growth levers for this unit? And is there any lock-in noncompete or buyout arrangement with the 3 doctor promoters? And is there any part to 100% ownership going forward?

Okay. And what will be the growth levers from the Malad hospital?